Built for clinics that already have patients.
Revival RX Partners exists to build the operating program behind a peptide service line — for practices that have the patients and the licence, and need the machinery.
The operating program, not the pitch deck.
Clinics rarely struggle in this category because the clinical side is wrong. They struggle because nobody helped them build the operating program around it: the service menu, the pricing and margin model, the inventory plan, the patient workflows, the staff training, and the supply relationships underneath all of it.
We build those, with your team, in ninety days, and hand them over running. There is no franchise agreement, no certification to buy, and no chemistry degree required on your side.
What we are not: a research-peptide marketplace, a course catalog, or a broker with no stake in whether the program works. We do not put a clinic into supply we would not put our own name on.
Built by someone inside the peptide business.
Revival RX Partners was founded by Brad Fogeltanz, who has spent the last several years operating inside the peptide industry — sourcing from 503A and 503B pharmacies, working with clinics on protocols and programs, and watching closely which builds scale and which stall.
The pattern is consistent. Clinics rarely struggle here because the clinical side is wrong. They struggle because nobody helped them build the operating program around it: the menu, the pricing, the inventory, the workflows, the staff training, the supply relationships. All of that has to exist before the first patient, and most clinics discover it after the first order.
The 90-Day Launch Program was built to close that gap. Not a course, not a catalog, not a franchise — an implementation team that builds the program alongside your staff and hands it over running.
Five things we hold to.
We build it with your team, not for them.
A program delivered as a document dies in a drawer. Staff training and workflow design happen alongside your people, because the test of this work is whether it still runs on day 91.
Operational, never clinical.
We build menus, pricing, inventory and workflow. What any individual patient should receive is a decision for your licensed practitioners, and we do not cross that line in either direction.
Conservative before confident.
Menus start narrow and par levels start small, then both expand against real demand. Tying up cash in compounds your patients turn out not to want is the most common expensive mistake in this category.
We say what we cannot promise.
Compounded peptides are not FDA-approved, availability shifts as regulatory categories move, advertising is genuinely restricted, and no revenue outcome is guaranteed. A partner who leaves that out is a liability, not an asset.
Limited intake, on purpose.
We cap how many clinics enter each cohort. The alternative is a roster the implementation team cannot stay hands-on with, which is the failure mode of every consulting business that scaled faster than it could deliver.
Where the lines are.
- Pharmacy partners
- Licensed 503A compounding pharmacies, and FDA-registered 503B outsourcing facilities where a compound and state allow it. No grey-market sourcing.
- Our role
- Consulting and sourcing. We are not a pharmacy, do not compound or dispense, and never take possession of product.
- Prescribing
- Independent licensed practitioners through our nurse-practitioner platform partner. We do not direct clinical judgment, and no compensation is tied to prescription volume.
- Claims
- Compounds described by category and mechanism. No outcome claims for compounded preparations, which are not FDA-approved.
- Patient data
- The clinic is the covered entity. We do not require access to protected health information, and execute a business associate agreement where an engagement would involve it.
- Intake
- Limited cohorts, so the implementation team stays hands-on through every rollout.
Questions about working with us.
Is this a franchise or a licensing agreement?
What happens when the ninety days end?
Do you take equity or a share of our revenue?
How many clinics do you take at once?
We already have pharmacy relationships. Is this still worth it?
Do you work with clinics outside the United States?
Your patients are already asking about peptides.Make sure your clinic is ready to answer.
Build and launch your peptide program with Revival RX Partners in 90 days.
Important
- Revival RX Partners is a consulting and sourcing partner. It is not a pharmacy, does not compound or dispense medication, and does not practice medicine or provide medical advice.
- All medications are dispensed by licensed partner pharmacies against valid prescriptions issued by your clinic's licensed prescribers.
- Compounded peptides are not FDA-approved products. Availability, regulatory status, and pharmacy capability vary by compound and by state, and are subject to change.
- Nothing on this page is a guarantee of revenue, patient volume, or clinical outcomes. Revenue figures shown are illustrative and generated from values you enter.